Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular Risk in Young Finns study (Q47352273)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 September 2011

Language	Label	Description	Also known as
English	Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular Risk in Young Finns study	scientific article published on 29 September 2011

Statements

scholarly article

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular Risk in Young Finns study (English)

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

metabolic syndrome

1 reference

based on heuristic

inferred from title

Costan G Magnussen

2

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

3

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

object named as

Markus Juonala

13

0 references

object named as

Mika Kähönen

7

0 references

Terho Lehtimäki

11

object named as

Terho Lehtimäki

1 reference

Europe PubMed Central

14 January 2018

object named as

Antti J Kangas

5

0 references

9

object named as

Antti Jula

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

14

object named as

Olli T Raitakari

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

Mika Ala-Korpela

12

object named as

Mika Ala-Korpela

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

author name string

Juha Koskinen

1

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

Pasi Soininen

4

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

Jorma Sa Viikari

6

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

Britt-Marie Loo

8

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

Markku Ahotupa

10

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

publication date

29 September 2011

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

European Journal of Preventive Cardiology

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

19

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

6

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

1296-1303

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

The metabolic syndrome--a new worldwide definition

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Obesity and atherogenic dyslipidemia

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Metabolic syndrome: focus on dyslipidemia

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study).

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

LDL particle size in relation to intima-media thickness and plaque occurrence in the carotid and femoral arteries in patients with hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Small, dense low-density-lipoproteins and the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Oxidised LDL modulate adipogenesis in 3T3-L1 preadipocytes by affecting the balance between cell proliferation and differentiation

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Baseline diene conjugation in LDL lipids: an indicator of circulating oxidized LDL.

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young adults: the cardiovascular risk in young Finns study.

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Arterial structure and function after recovery from the metabolic syndrome: the cardiovascular risk in Young Finns Study.

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east-west difference

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA).

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Oxidative stress and insulin resistance: the coronary artery risk development in young adults study.

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Sphingomyelinase induces aggregation and fusion of small very low-density lipoprotein and intermediate-density lipoprotein particles and increases their retention to human arterial proteoglycans

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Characterization of systemic metabolic phenotypes associated with subclinical atherosclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1741826711425343

21 January 2018

Identifiers

10.1177/1741826711425343

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/21960651

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47352273&oldid=2153242519"